Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,296,497
-$3,471,224 QoQ
Shares Held
39,480
-21.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#445
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. AMGN ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
This page
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,296,497 | 39,480 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $17,767,721 | 50,498 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,077,535 | 46,065 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,683,644 | 41,402 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,858,048 | 42,470 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,559,203 | 40,312 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,971,674 | 30,585 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,460,182 | 38,671 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,274,598 | 39,285 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,810,978 | 16,921 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,112,632 | 10,807 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,809,079 | 10,452 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,788,127 | 12,558 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,403,236 | 9,941 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,786,477 | 6,802 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,656,915 | 7,351 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,739,838 | 7,151 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,562,882 | 6,463 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $626,091 | 2,783 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $991,799 | 4,664 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $1,080,056 | 4,431 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $1,475,940 | 5,932 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $1,155,118 | 5,024 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $712,664 | 2,804 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $652,388 | 2,766 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $682,997 | 3,369 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||